Ethambutol

Class: Ethylenediamine

Details of activity:	Active against Mycobacterium tuberculosis; targets mycolic cell wall synthesis
Description:	Synthetic compound
Year first mentioned:	1961
Highest developmental phase:	Approved by FDA in 1967
Development status:	Approved

Chemical structure(s):
Canonical SMILES:	CC[C@@H](CO)NCCN[C@@H](CC)CO
Isomeric SMILES:	CC[C@@H](CO)NCCN[C@@H](CC)CO
InChI:	InChI=1S/C10H24N2O2/c1-3-9(7-13)11-5-6-12-10(4-2)8-14/h9-14H,3-8H2,1-2H3/t9-,10-/m0/s1
InChI Key:	AEUTYOVWOVBAKS-UWVGGRQHSA-N
Structure link:	https://pubchem.ncbi.nlm.nih.gov/compound/14052

External links:
Guide to Pharmacology:	ethambutol
Main Source:	https://www.atsjournals.org/doi/10.1164/arrd.1961.83.6.891?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed